Top Suppliers:I want be here
Related CAS#:
568-75-2 100678-36-2
70234-58-1 78776-41-7
80733-96-6 18787-77-4
28622-64-2 64365-35-1
568-70-7 16354-50-0

568-75-2

568-75-2 structure
568-75-2 structure
  • Name: 7-hydroxymethyl-12-methylbenz(a)anthracene
  • Chemical Name: (12-methylbenzo[a]anthracen-7-yl)methanol
  • CAS Number: 568-75-2
  • Molecular Formula: C20H16O
  • Molecular Weight: 272.34000
  • Create Date: 2016-04-02 07:20:43
  • Modify Date: 2024-01-09 12:36:42
Name (12-methylbenzo[a]anthracen-7-yl)methanol
Synonyms BENZ(a)ANTHRACENE-7-METHANOL,12-METHYL
[3H]-7-Hydroxymethyl-12-methylbenz[a]anthracene
7-Hydroxymethyl-12-methylbenz<a>anthracen
12-Hydroxymethyl-7-methylbenz<a>anthracen
7-Hydroxymethyl-12-Dimethylbenzo<a>anthracene
7-(Hydroxymethyl)-12-methylbenz(a)anthracene
12-Methylbenz[a]anthracene-7-methanol
Density 1.227g/cm3
Boiling Point 523.8ºC at 760 mmHg
Molecular Formula C20H16O
Molecular Weight 272.34000
Flash Point 225.9ºC
Exact Mass 272.12000
PSA 20.23000
LogP 4.94690
Index of Refraction 1.757

CHEMICAL IDENTIFICATION

RTECS NUMBER :
CW8750000
CHEMICAL NAME :
Benz(a)anthracene-7-methanol, 12-methyl-
CAS REGISTRY NUMBER :
568-75-2
LAST UPDATED :
199709
DATA ITEMS CITED :
26
MOLECULAR FORMULA :
C20-H16-O
MOLECULAR WEIGHT :
272.36
WISWESSER LINE NOTATION :
L D6 B666J C1 J1Q

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
73 mg/kg
TOXIC EFFECTS :
Blood - normocytic anemia Blood - granulocytopenia Blood - leukopenia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
150 mg/kg/39D-I
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
25 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - increased incidence of tumors in susceptible strains
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
16 mg/kg/17W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Skin and Appendages - tumors Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
400 mg/kg/10W-I
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Tumorigenic - tumors at site of application
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
100 mg/kg
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Blood - leukemia
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 12 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - extra-embryonic structures (e.g., placenta, umbilical cord)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - cytological changes (including somatic cell genetic material)
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 13 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - endocrine system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Specific Developmental Abnormalities - Central Nervous System Reproductive - Specific Developmental Abnormalities - musculoskeletal system
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intravenous
DOSE :
25 mg/kg
SEX/DURATION :
female 8 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Specific Developmental Abnormalities - eye/ear Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA adduct

MUTATION DATA

TYPE OF TEST :
DNA adduct
TEST SYSTEM :
Mammal - species unspecified Lymphocyte
DOSE/DURATION :
50 gm/L
REFERENCE :
RCOCB8 Research Communications in Chemical Pathology and Pharmacology. (PJD Pub. Ltd., P.O. Box 966, Westbury, NY 11590) V.1- 1970- Volume(issue)/page/year: 22,345,1978
27018-50-4 structure

27018-50-4

~%

568-75-2 structure

568-75-2
Literature: Flesher; Soedigdo; Kelley Journal of medicinal chemistry, 1967 , vol. 10, # 5 p. 932 - 936
57-97-6 structure

57-97-6

~%

568-75-2 structure

568-75-2

2518-01-6 structure

2518-01-6
Literature: Uibopuu, Kh. M.; Gubergritis, M. Ya.; Perin-Roussel, O.; Perin, F.; Jacquignon, P. S. J. Appl. Chem. USSR (Engl. Transl.), 1982 , vol. 55, # 11 p. 2519 - 2528,2277 - 2285

Chemsrc provides CAS#:568-75-2 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 568-75-2 | Chemsrc address: https://www.chemsrc.com/en/baike/168653.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved